Literature DB >> 10679584

[Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat].

L Benoit1, C Duvillard, J L Beltramo, P Brunet-Lecomte, B Chauffert.   

Abstract

OBJECTIVE: To evaluate and compare the effects of cytoreductive surgery with intraperitoneal cisplatin and epinephrine on peritoneal carcinomatosis in the rat.
MATERIAL AND METHODS: Twenty-day old peritoneal carcinomatosis was obtained after intraperitoneal injection of 1 x 10(6) DHD/K12/PROb cells into BDIX rats. The surgical treatment included electric fulguration of the peritoneal tumors with spleen and omentum removal while intraperitoneal chemotherapy included platinum (3 mg/kg) associated with epinephrine (2 mg/kg).
RESULTS: Surgery did not increase rat survival unlike cisplatin or cisplatin/epinephrine chemotherapy. Intraperitoneal chemotherapy alone with cisplatin +/- epinephrine increased survival but did not provide cure. Surgery followed by intraperitoneal cisplatin and epinephrine cured four out of five twenty-day old peritoneal carcinomatosis.
CONCLUSION: Surgery combined with intraperitoneal cisplatin and epinephrine could be an efficient treatment for peritoneal carcinomatosis in man.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679584

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

1.  Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model.

Authors:  Arndt Hribaschek; Roger Kuhn; Matthias Pross; Frank Meyer; Jörg Fahlke; Karsten Ridwelski; Carsten Boltze; Hans Lippert
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

2.  An in vivo rat model for early development of colorectal cancer metastasis to liver.

Authors:  John H P Robertson; Shi Yu Yang; Arthur M Iga; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.